您当前的位置:
首页 >
文章列表页 >
CD36 promotes tubular ferroptosis by regulating the ubiquitination of FSP1 in acute kidney injury
Full-length article | 更新时间:2024-02-04
    • CD36 promotes tubular ferroptosis by regulating the ubiquitination of FSP1 in acute kidney injury

    • Genes & Diseases   Vol. 1, Issue 1, Pages: 449-463(2024)
    • 作者机构:

      1. Department of Nephrology, The Second Affiliated Hospital, Chongqing Medical University,Chongqing,China,400010

      2. Department of Cell Biology and Genetics, Chongqing Medical University,Chongqing,China,400016

      3. Centre for Nephrology, Royal Free and University College Medical School, University College London, Royal Free Campus, Rowland Hill Street, London NW3 2PF, United Kingdom

      4. Centre for Lipid Research, Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Chongqing Medical University,Chongqing,China,400016

      5. Kuanren Laboratory of Translational Lipidology, Centre for Lipid Research, Second Affiliated Hospital of Chongqing Medical University,Chongqing,China,400010

    • DOI:10.1016/j.gendis.2022.12.003    

      CLC:
    • Published:2024,

      Published Online:1 January 2024,

    扫 描 看 全 文

  • Yixin Ma, Lili Huang, Zheng Zhang, et al. CD36 promotes tubular ferroptosis by regulating the ubiquitination of FSP1 in acute kidney injury. [J]. Genes & Diseases 1(1):449-463(2024) DOI: 10.1016/j.gendis.2022.12.003.

  •  
  •  
查看原文

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Mitochondria-related signaling pathways involved in breast cancer regulate ferroptosis
Potential relationship between autophagy and ferroptosis in myocardial ischemia/reperfusion injury
All-trans retinoic acid inhibits the malignant behaviors of hepatocarcinoma cells by regulating ferroptosis
Regulation of ferroptosis in cancer cells by YAP/TAZ and Hippo pathways: The therapeutic implications
Ferroptosis: An emerging therapeutic opportunity for cancer

Related Author

Huijuan Dai
Aijun Sun
Weihang Zhou
Xiaonan Sheng
Ye Li
Xinrui Dong
Xianhe Lin
Yu Yang

Related Institution

Department of Thyroid and Breast Oncological Surgery, Xuzhou Medical College Affiliated Huaian Hospital
Department of Breast Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University
Anhui Medical University
Cardiology Department, The First Affiliated Hospital of Anhui Medical University
Molecular Oncology Laboratory, Department of Surgery, The University of Chicago Medical Centre
0